Get it on Google Play

Kamada receives FDA approval for rabies testing laboratory

June 1, 2026 7:02 AM EDT Send to a Friend
Kamada Ltd. (NASDAQ: KMDA) announced that the U.S. Food and Drug Administration has approved the company's new in-house Rapid Fluorescent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login